|
Volumn 20, Issue 24, 2013, Pages 1928-1932
|
TACE combined PMCT sequential own cancer vaccine and immunoeffector cells to treat large hepatocellular carcinoma clinical observation
|
Author keywords
Adoptive cellular immunotherapy; Carcinoma, hepatocellular; Chemoembolization; Microwave ablation
|
Indexed keywords
ALPHA FETOPROTEIN;
CANCER VACCINE;
IODINATED POPPYSEED OIL;
TRANSCRIPTION FACTOR FOXP3;
TUMOR ANTIGEN;
ANTICOAGULANT THERAPY;
ARTICLE;
CANCER IMMUNIZATION;
CANCER IMMUNOTHERAPY;
CANCER PATIENT;
CANCER SIZE;
CANCER SURVIVAL;
CD4 CD8 RATIO;
CD4+ CD25+ T LYMPHOCYTE;
CELL LYSATE;
CHEMOEMBOLIZATION;
CLINICAL EVALUATION;
CLINICAL OBSERVATION;
COLOR ULTRASOUND FLOWMETRY;
COMPUTER ASSISTED TOMOGRAPHY;
CONTRAST ENHANCEMENT;
CONTROLLED STUDY;
CYTOKINE INDUCED KILLER CELL;
DENDRITIC CELL;
FOLLOW UP;
GAMMA DELTA T LYMPHOCYTE;
HEPATOMA CELL;
HUMAN;
IMMUNOLOGICAL PARAMETERS;
INOPERABLE CANCER;
LIVER CELL CARCINOMA;
LIVER FUNCTION;
MAJOR CLINICAL STUDY;
NATURAL KILLER CELL;
QUALITY OF LIFE;
RANDOMIZED CONTROLLED TRIAL;
SURVIVAL RATE;
SURVIVAL TIME;
TREATMENT RESPONSE;
ULTRASONIC GUIDED WATER CIRCULATORY COOLING PERCUTANEOUS MICROWAVE COAGULATION THERAPY;
VASCULARIZATION;
|
EID: 84897144128
PISSN: 16735269
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (6)
|
References (16)
|